Skip to main content
Premium Trial:

Request an Annual Quote

Study Suggests BG's Galectin-3 Test Useful in Predicting Hospital Readmissions and Cardiac Events


BG Medicine this week announced the publication of a multicenter clinical trial that found that the company's BGM Galectin-3 test was useful in predicting unplanned hospital readmissions and fatal events in heart failure patients.

The study, which was detailed in a paper published this month in the International Journal of Cardiology, followed 419 heart failure patients from four Spanish hospitals over a 12-month period and found that including galectin-3 testing in hospital discharge risk assessments identified elevated risk in roughly 25 percent of patients who would have otherwise been categorized as low risk.

The study also found that heart failure patients with elevated galectin-3 levels had an 84 percent higher chance of experiencing hospital readmission or a fatal event than patients with lower levels.

Hospital readmissions have become a key focus for BG Medicine's commercialization plans for the BGM Galectin-3 test. The company shifted toward this application last year in response to new guidelines implemented by the US Centers for Medicare and Medicaid Services that penalize hospitals with high patient readmission rates. The IJC study follows two studies the company published in March that indicated that serial evaluation of galectin-3 levels could help clinicians identify heart failure patients at increased risk of unplanned hospital readmissions.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.